Ashvattha Therapeutics
Christine S. has over 18 years of work experience in the pharmaceutical industry. Christine began their career in 2003 as a Senior Project Coordinator, Senior Research Associate, and Research Associate III at Nektar Therapeutics. In 2008, they joined Novartis as a Program Manager, Senior Project Management Specialist, and Specialist Project Manager. In 2018, they were hired as a Senior Program Manager at Orchard Therapeutics. Most recently, in 2020, they joined Jasper Therapeutics as an Associate Director Project Management and in 2022 they were appointed as Director, CMC Project Management at Ashvattha Therapeutics, Inc.
Christine S. graduated from the University of California, Berkeley with a Bachelor of Arts (B.A.) in Cell/Cellular and Molecular Biology.
This person is not in any teams
Ashvattha Therapeutics
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.